Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

NCT07029581 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Lewy Body Dementia Psychosis

Interventions

DRUG: ACP-204
DRUG: Placebo

Sponsor

ACADIA Pharmaceuticals Inc.